Professor Dame Lesley Fallowfield at the Haematology Nurses and Healthcare Professionals Group Educational Conference
Professor Dame Lesley Fallowfield attended the Haematology Nurses and Healthcare Professionals Group Educational Annual Conference in Zurich, focused on supporting health care professionals through haematology and delivering optimal care to patients and supporting their families. Professor Fallowfield presented on a talk titled 'No news is not good news: Information preferences of patients', demonstrating that most cancer patients prefer to be well informed about diagnosis, prognosis, therapeutic options and side-effects of their treatment.
News item posted 15/11/2024
Professor Dame Lesley Fallowfield attends BCRF Annual Symposium
Professor Dame Lesley Fallowfield recently attended the Breast Cancer Research Foundation's annual symposium in New York. Professor Fallowfield is among one of the 245 distinguished breast cancer researchers who receive annual funding from BCRF. This year, generous donors helped raise over $2.7 million in just two hours. Previously, BCRF funding has supported courses like the TRUSTING workshops.
News item posted 29/10/2024
Talking about sad, bad and difficult things
This month's issue of 'The Psychologist' features an interview with Professor Dame Lesley Fallowfield talking about her work helping those who are 'talking about sad, bad, and plain difficult things'. You can view the article on The Psychologist website
News item posted 29/10/2024
Professor Dame Lesley Fallowfield at Young and Strong
Professor Dame Lesley Fallowfield recently attended the Young and Strong Forum in Boston, focused on supporting young adults with breast cancer. She was the keynote speaker and addressed effective communication strategies for those with cancer in conversations with their care teams and loved ones. Additionally, she co-facilitated a session titled 'Strengthening Ties: Loved Ones Supporting Each Other'. While in Boston, Professor Dame Fallowfield also presented a lecture at the Dana-Farber Cancer Institute titled 'Talking About Risk and Uncertainty in the Context of Genetic and Genomic Testing'.
News item posted 28/10/2024
SHORE-C at European Organisation For Research and Treatment of Cancer Conference
Drs. Sally Wheelwright and Qi Ling attended the European Organisation for Research and Treatment of Cancer's two-day autumn conference in Innsbruck, where they presented updates on their educational project to develop a quality-of-life curriculum for oncology.
News item posted 25/10/2024
SHORE-C at International Psychosocial Oncology Society conference
Drs Helena Harder and Val Shilling attended the 3-day International Psychosocial Oncology Society conference in Maastricht, the Netherlands. They presented posters and a short verbal presentation from the PEATY and IMPACTOR studies which looked at quality of life impacts and sided effects of abemaciclib and endocrine treatment for women with breast cancer.
News item posted 08/10/2024
Professor Lesley Fallowfield presents at Novartis Breast Cancer Nurses Conference
Professor Dame Lesley Fallowfield attended the Novartis Breast Cancer Nurses Conference in Birmingham, where she presented on the topic of metastatic breast cancer titled 'Living with Metastatic Breast Cancer: Difficult conversations'. Additionally, she led an interactive presentation titled 'They just don't know what to say or do', exploring how friends and family can better support those living with metastatic breast cancer.
News item posted 04/10/2024
Professors Fallowfield and Jenkins facilitate the TARGET2 Workshop
Professors Fallowfield and Jenkins facilitated the 'Talking About Risk in the Context of Genomic Tests' (TARGET) educational programme in Brighton. The workshop focuses on improving communication skills for all health care professionals working with breast cancer patients, particularly in relaying results from the Oncotype and Prosigna genomic tests. There are more workshops scheduled for 2025, for more information please click here.
News item posted 04/10/2024
Professor Lesley Fallowfield at the Controversies In Breast Cancer Conference
Professor Dame Lesley Fallowfield attended the Controversies in Breast Cancer (CoBrCa) in Edinburgh and chaired the symposium titled 'What is the true utility of Genomic Testing in Early Breast Cancer? A closer look at intrinsic subtyping and Prosigna', presenting on 'How well do healthcare professionals and patients understand the information provided by genomic test reports?' and 'Managing oestrogen deprivation effects of therapy: Real world patient'.
News item posted 30/09/2024
SHORE-C at the ICPV Conference
Professors Fallowfield and Jenkins recently attended the two-day Summer School at Sussex, for the Independent Cancer Patients' Voice, which was funded by ComSkills. They presented on the topic "The Robot Will See You Now," discussing technological advances in communication within healthcare. Research Fellow Rachel Starkings also participated, presenting on "Bodyswaps," a virtual learning tool designed to help navigate difficult conversations. Additionally, Dr. Val Shilling gave a presentation on "How Patients Have Helped Shape and Implement Patient-Reported Outcome Measures."
News item posted 04/09/2024
New Work Experience
Lewis has joined the SHORE-C team this week for work experience. Some of his roles include archiving publications, paper management and creating resources for an upcomimg conference.
News item posted 21/08/2024
New Article for TRUSTING Published
Professor Valerie Jenkins and colleagues, have published a new article titled 'Roll-out of an educational workshop to improve knowledge and self-confidence of healthcare professionals engaged in mainstreaming of breast cancer genetics'. The paper focuses on improving health care professionals' knowledge, communication and self confidence in breast cancer genetics through the use of TRUSTING (Talking about Risk & uncertainties of Testing in Genetics) educational materials, delivered by skilled facilitators in small group workshops. The article can be found here
News item posted 26/07/2024